SEARCH

SEARCH BY CITATION

References

  • Becker, U., Bartl, K. & Wahlefeld, A.W. (1984) A functional photometric assay for plasma fibrinogen. Thrombosis Research, 35, 475484.
  • Blanco, M., Colesse, G., Woodhams, B. & Gourmelin, Y. (2000) Stability of coagulation factors in frozen plasma. Haemostasis, 30, 3738a.
  • Blomback, B. & Blomback, M. (1956) Preparation of human fibrinogen fraction 1–2. Arkiv for Kemi, 10, 415443.
  • Van Der Bom, J.G., De Maat, M.P.M., Bots, M.L., Hofman, A., Kluft, C. & Grobbee, D.E. (1997) Seasonal variation in fibrinogen in the Rotterdam Study. Thrombosis and Haemostasis, 78, 10591062.
  • Cambas, J.P., Bierme, R., Martinon, J.C. & Dousset, B. (1985) Evaluation des performances d'un automate en coagulation: l'Electra 700. Nouvelle Revue Francaise D'hematologie, 25, 313320.
  • Chantarangkul, V., Tripodi, A. & Mannucci, P.M. (1987) Evaluation of a fully automated centrifugal analyzer for performance of hemostasis tests. Clinical Chemistry, 33, 18881890.
  • Chantarangkul, V., Tripodi, A. & Mannucci, P.M. (1994) Results of a collaborative study for fibrinogen measurement. Evidence that the use of a common calibrator improves interlaboratory agreement. Blood Coagulation and Fibrinolysis, 5, 761766.
  • Chitolie, A., Mackie, I.J., Grant, D., Hamilton, J.L. & Machin, S.J. (1994) Inaccuracy of the ‘derive’ fibrinogen measurement. Blood Coagulation and Fibrinolysis, 5, 955957.
  • Chitolie, A., Mackie, I.J. & Machin, S.J. (1998) The type of thromboplastin reagent has important effects on the PT-derived fibrinogen potency. Laboratory Hematology, 4, 149155.
  • Clauss, A. (1957) Gerinnungsphysiologische schnellmethode zur bestimmung des fibrinogens. Acta Haematologica, 17, 237246.
  • Cremer, P., Nagel, D., Labrot, B., Mann, H., Muche, R., Elster, H. & Seidel, C. (1994) Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Gottingen Risk Incidence and Prevalence Study (GRIPS). European Journal of Clinical Investigation, 24, 444453.
  • De Cristofaro, R. & Landolfi, R. (1998) Measurement of plasma fibrinogen concentration by the prothrombin-time-derived method: applicability and limitations. Blood Coagulation and Fibrinolysis, 9, 251259.
  • Cushman, M., Cornell, E.S., Howard, P.R., Bovill, E.G. & Tracy, R.P. (1995) Laboratory methods and quality assurance in the cardiovascular health study. Clinical Chemistry, 41, 264270.
  • Eliasson, M., Evrin, P.E., Lundblad, D., Asplund, K. & Ranby, M. (1993) Influence of gender, age and sampling time on plasma fibrinolytic variables and fibrinogen. A population study. Fibrinolysis, 7, 18.
  • Gaffney, P.J. & Wong, M.Y. (1992) Collaborative study of a proposed international standard for plasma fibrinogen measurement. Thrombosis and Haemostasis, 68, 428432.
  • Hantgan, R.R., Francis, C.W. & Marder, V.J. (1994) Fibrinogen structure and physiology. In: Hemostasis and Thrombosis: Basic Principles & Clinical Practice (ed. by R.W.Colman, J.Hirsh, V.J.Marder & E.W. Salzman), pp. 277300. JB Lippincott, Philadelphia.
  • Haverkate, F. & Samama, M. (1995) Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC subcommittee on fibrinogen. Thrombosis and Haemostasis, 73, 151161.
  • Hoffmann, J.J.M.L. & Verhappen, M.A.L. (1988) Automated nephelometry of fibrinogen: analytical performance and observations during thrombolytic therapy. Clinical Chemistry, 34, 21352140.
  • Humphries, S.E., Henry, J.A. & Montgomery, H.E. (1999) Gene–environment interaction in the determination of levels of haemostatic variables involved in thrombosis and fibrinolysis. Blood Coagulation and Fibrinolysis, 10, s17s21.
  • Jacobsson, K. (1955) Studies in the determination of fibrinogen in human blood plasma. Scandinavian Journal of Clinical Laboratory Investigation, 7, 154.
  • Kitchen, S., Jennings, I. & Preston, F.E. (1995) Comparison of fibrinogen determinations using a Clauss assay and two prothrombin time derived methods. Thrombosis and Haemostasis, 73, 1245a.
  • Kluft, C. & Lansink, M. (1997) Effect of oral contraceptives on haemostasis variables. Thrombosis and Haemostasis, 78, 315326.
  • Lawrie, A.S., McDonald, S.J., Purdy, G., Mackie, I.J. & Machin, S.J. (1998) Prothrombin time derived fibrinogen determination on the Sysmex CA-6000™. Journal of Clinical Pathology, 51, 462466.
  • Lowe, G.D.O. & Rumley, A. (1999) Use of fibrinogen and fibrin D-dimer in prediction of arterial thrombotic events. Thrombosis and Haemostasis, 82, 667672.
  • Lowe, G.D.O., Rumley, A., Woodward, M., Morrison, C.E., Philippou, H., Lane, D.A. & Tunstall-Pedoe, H. (1997) Epidemiology of coagulation factors, inhibitors and activation markers: The third Glasgow MONICA survey. I. Illustrative reference ranges by age, sex and hormone use. British Journal of Haematology, 97, 775784.
  • Ludlam, C.A., Bennett, B., Fox, K.A.A., Lowe, G.D.O. & Reid, A.W. (1995) Guidelines for the use of thrombolytic therapy. Blood Coagulation and Fibrinolysis, 6, 273285.
  • De Maat, M.P.M., Lowe, G.D.O. & Haverkate, F. (1999) Fibrinogen. In: Laboratory Techniques in Thrombosis: A Manual (ed. by J.Jespersen, R.M.Bertina & F.Haverkate), pp. 7988. Kluwer Academic Publishers, Dordrecht.
  • Machin, S.J. & Mackie, I.J. (1993) Routine measurement of fibrinogen concentration: not clinically feasible. British Medical Journal, 307, 882883.
  • Mackie, I.J. & Machin, S.J. (1989) Laboratory Haematology: An Account of Laboratory Techniques (ed. by I.Chanarin), pp. 279280. Churchill Livingstone, Edinburgh.
  • Mackie, I.J., Lawrie, A.S., Kitchen, S., Gaffney, P.J., Howarth, D., Lowe, G.D.O., Martin, J., Purdy, G., Rigsby, P. & Rumley, A. (2002) A performance evaluation of commercial fibrinogen reference preparations and assays for Clauss and PT-derived fibrinogen. Thrombosis and Haemostasis, 87, 9971005.
  • Marder, V.J. & Sherry, S. (1988) Thrombolytic therapy: current status. New England Journal of Medicine, 318, 15121520, 1585–1595.
  • MDA (1999) Medical Devices Agency Evaluation Report: Fibrinogen Standards and Reference preparations. MDA 99/47 ISBN 184182 0784. Her Majesty's Stationery Office, Norwich.
  • MDA (2000) Medical Devices Agency Evaluation Report: Fibrinogen Assay reagents and Methods. MDA 2000/01 ISBN 184182 139X. Her Majesty's Stationery Office, Norwich.
  • De Metz, M. & Van Wersch, J.W.J. (1987) Use of a centrifugal analyzer for a chromogenic prothrombin time, a chromogenic activated partial thromboplastin time and a kinetic fibrinogen assay in a routine hospital laboratory. Haemostasis, 17, 254259.
  • Natelson, E.A. & Dooley, D.F. (1974) Rapid determination of fibrinogen by thrombokinetics. American Journal of Clinical Pathology, 61, 828833.
  • NCCLS (1998) Collection, Transport and Processing of Blood Specimens for Coagulation Testing and General Performance of Coagulation assays: Approved Guideline 3rd edn. NCCLS, H21-A3, 18, number 20.
  • Nieuwenhuizen, W. & Bos, R. (1999) Soluble fibrin and degradation products of fibrinogen (FgDP), fibrin (FbDP; D-dimer) and total of FgDP and FbDP (TDP). In: Laboratory Techniques in Thrombosis: A Manual (ed. by J.Jespersen, R.M.Bertina & F.Haverkate), pp. 275284. Kluwer Academic Publishers, Dordrecht.
  • Oosting, J.D. & Hoffmann, J.J.M.L. (1997) Evaluation of an automated photometric fibrinogen assay. Blood Coagulation and Fibrinolysis, 8, 321326.
  • Palareti, G., Maccaferri, M., Manotti, C., Tripodi, A., Chantarangkul, V., Rodeghiero, F., Ruggeri, M. & Mannucci, P.M. (1991) Fibrinogen assays: a collaborative study of six different methods. C.I.S.M.E.L Comitaro Italiano Per la Standardizzione Dei Methodi in Ematologia E Labatorio, 37, 714719.
  • Rampling, M.W. & Gaffney, P.J. (1976) Measurement of fibrinogen in plasma. In: Progress in Chemical Fibrinolysis & Thrombosis (ed. by J.F.Davidson, M.M.Samama & P.C. Desnoyers), Vol. 2, pp. 91105. Raven Press, New York.
  • Ratnoff, O.D. & Menzie, C. (1951) A new method for the determination of fibrinogen in small samples of plasma. Journal of Laboratory and Clinical Medicine, 37, 316320.
  • Rosenson, R.S., Staffileno, B.A. & Tangney, C.C. (1998) Effects of tourniquet technique, order of draw, and sample store on plasma fibrinogen. Clinical Chemistry, 44, 688690.
  • Rossi, E., Mondonico, P., Lombardi, A. & Preda, L. (1988) Method for determination of functional (clottable) fibrinogen by the new family of ACL coagulometers. Thrombosis Research, 52, 453468.
  • Swain, W. & Feders, M.B. (1967) Fibrinogen assay. Clinical Chemistry, 13, 10261028.
  • Sweetnam, P.M., Thomas, H.F., Yarnell, J.W.G., Beswich, A., Baker, I.A. & Elwood, P.C. (1996) Fibrinogen, viscosity and the 10-year incidence of ischaemic heart disease. The Caerphilly and Speedwell studies. European Heart Journal, 17, 18141820.
  • Sweetnam, P.M., Yarnell, J.W.G., Lowe, G.D.O., Baker, I.A., O'Brien, J.R., Rumley, A., Etherington, M.D., Whitehead, P.J. & Elwood, P.C. (1998) The relative predictive power of heat-precipitation nephelometric and clottable (Clauss) fibrinogen in the prediction of ischaemic heart disease: the Caerphilly and Speedwell studies. British Journal of Haematology, 100, 582588.
  • Thompson, S.G., Martin, J.C. & Meade, T.W. (1987) Sources of variability in coagulation factor assays. Thrombosis and Haemostasis, 58, 10731077.
  • UK National External Quality Assessment Scheme (NEQAS) for Blood Coagulation (2000) Report on Survey 120, Sheffield.
  • Vermylen, C., De Vreker, R.A. & Verstraete, M. (1963) A rapid enzymatic method for assay of fibrinogen fibrin polymerization time (FPT test). Clinica Chimica Acta, 8, 418424.
  • Whicher, J.T. & Dieppe, P.A. (1985) Acute phase proteins. Clinical Immunology and Allergy, 5, 425446.
  • World Health Organisation Report (1999) Use of Anticoagulants in Diagnostic Laboratory Investigations. World Health Organisation/DIL/LAB/99, 1 Rev 1.